Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S0140-6736(20)31023-0 http://scihub22266oqcxt.onion/10.1016/S0140-6736(20)31023-0 32423580!7190306!32423580     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet 2020 ; 395 (10236): 1525-1527 Nephropedia Template TP {{tp|p=32423580|t=2020. Remdesivir for COVID-19: challenges of underpowered studies |pdf=|usr=}}{{32423580}} gab.com Text Remdesivir for COVID-19: challenges of underpowered studies JO: Lancet http://www.kidney.de/pget.php?&tw=1&pmid=32423580 #FOAvip ä Twit Text FOAVip Remdesivir for COVID-19: challenges of underpowered studies ????Lancet http://www.kidney.de/pget.php?&tw=1&pmid=32423580 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32423580 #FOAvip English Wikipedia <ref>{{Cite pmid|32423580}}</ref> Remdesivir for COVID-19: challenges of underpowered studies #MMPMID32423580 Norrie JD Lancet 2020[May]; 395 (10236): 1525-1527 PMID32423580show ga ä |*Antiviral Agents/therapeutic use[MESH] |*Betacoronavirus[MESH] |*Coronavirus Infections[MESH] |Adenosine Monophosphate/analogs & derivatives[MESH] |Alanine/analogs & derivatives[MESH] |COVID-19[MESH] |Double-Blind Method[MESH] |Pandemics[MESH] |Pneumonia, Viral[MESH] |Randomized Controlled Trials as Topic[MESH]Remdesivir for COVID-19: challenges of underpowered studies (epmc).pdf DeepDyve Pubget Overpricing